Drug Type Small molecule drug |
Synonyms JKB 133, JKB-133, TJC-0133 |
Target |
Mechanism TLR4 antagonists(Toll like receptor 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis, Autoimmune | Preclinical | TW | - | |
Hepatitis, Autoimmune | Preclinical | TW | - | |
Nonalcoholic Steatohepatitis | Preclinical | TW | - | |
Nonalcoholic Steatohepatitis | Preclinical | TW | - |